Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Abbott Laboratories ( (ABT) ) has issued an announcement.
On February 20, 2026, Abbott Laboratories’ board of directors approved an amendment to the company’s by-laws to reduce the size of the board from thirteen to twelve members, effective April 24, 2026. The change signals a streamlined governance structure that may affect board dynamics and decision-making, though Abbott has not disclosed specific implications for leadership roles or strategic direction.
This adjustment to board composition comes as governance practices across the healthcare and broader corporate sectors increasingly emphasize board efficiency and alignment with strategic priorities. Investors and other stakeholders will likely monitor how the smaller board influences oversight, succession planning, and the company’s ability to respond to industry and regulatory developments.
The most recent analyst rating on (ABT) stock is a Buy with a $140.00 price target. To see the full list of analyst forecasts on Abbott Laboratories stock, see the ABT Stock Forecast page.
Spark’s Take on ABT Stock
According to Spark, TipRanks’ AI Analyst, ABT is a Outperform.
The score is driven primarily by strong underlying financial performance and constructive 2026 guidance with continued Devices/CGM strength and margin expansion. This is partially offset by very weak technical momentum (price below major moving averages with oversold indicators) and a premium valuation (P/E ~32) that reduces upside support.
To see Spark’s full report on ABT stock, click here.
More about Abbott Laboratories
Abbott Laboratories is a global healthcare company that operates in the medical devices, diagnostics, nutrition, and branded generic pharmaceuticals industries. The company develops and markets products that support patient care across hospitals, clinics, and consumer health markets worldwide, focusing on long-term growth in healthcare innovation and treatment outcomes.
Average Trading Volume: 8,980,143
Technical Sentiment Signal: Hold
Current Market Cap: $197B
Learn more about ABT stock on TipRanks’ Stock Analysis page.